Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Immfinity Biotechnologies
Vancouver, British Columbia, Canadaca.linkedin.com ↗
- Ownership
- Private
- Employees
- ~2
- Development stage
- Other
01
Overview
Immfinity Biotechnologies has developed a patented platform using synthetic biology, engineered immune cells, and next-generation DNA sequencing to accelerate the discovery and development of safe, effective immunotherapies. Their Tope-seq platform enables high-throughput selection of optimal therapeutic candidates. The science behind their approach has been published in Nature Communications, with early validation through patents in the US and Canada. They are currently working with a leading biopharma partner as an early adopter but have not yet advanced programs into clinical trials.
- Therapeutic areas
- Oncology
- Modalities
- Cell therapySynthetic biologyEngineered immune cellsNext-generation DNA sequencing
- Industry
- Drug Discovery Services
02
Partnerships
Collaboration with an undisclosed world-leading biopharma partner as an early adopter/customer for the Tope-seq platform
Beyond the preview
Go deeper on Immfinity Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immfinity Biotechnologies.